Kapnick Scott 4/A
4/A · AILERON THERAPEUTICS INC · Filed Aug 14, 2018
Insider Transaction Report
Form 4/AAmended
Kapnick Scott
Director
Transactions
- Purchase
Common Stock
2017-07-05$15.00/sh+66,666$999,990→ 66,666 total(indirect: See Footnote)
Footnotes (2)
- [F1]The amount of securities previously reported as beneficially owned by the Reporting Person inadvertently aggregated shares that the Reporting Person indirectly beneficially owned with shares that the Reporting Person directly beneficially owned following the transaction reported on the original Form 4. The correct number of shares that the Reporting Person indirectly beneficially owned following this transaction was 66,666 shares.
- [F2]These shares are directly owned by Jake86 LLC, for which the Reporting Person serves as investment manager. The Reporting Person disclaims beneficial ownership of the shares held by Jake86 LLC, except to the extent of his indirect pecuniary interest therein.